Status:

UNKNOWN

Stimulation of Sleep in Patients With Epilepsy

Lead Sponsor:

University Children's Hospital, Zurich

Collaborating Sponsors:

ETH Zurich

University of Zurich

Conditions:

Epilepsy

Eligibility:

All Genders

4-30 years

Phase:

NA

Brief Summary

Sleep slow waves (SSW) and the pathophysiological mechanisms of spike generation in patients with epilepsy are tightly linked. SSW are cortically generated oscillations (\~1 Hz) alternating between a ...

Detailed Description

The investigators aim to evaluate the effect of closed-loop auditory stimulation during sleep in healthy children, adolescents and adults, as well children, adolescents and adults with epilepsy. Durin...

Eligibility Criteria

Inclusion

  • Inclusion criteria
  • Participants of any gender
  • Children, adolescents and young adults (4-30 years old)
  • Right-handed
  • Written informed consent by the participant or, if applicable, by their legal guardian after receiving information about the study For healthy participants:
  • Good general health status
  • For patients with epilepsy:
  • Diagnosed with epilepsy
  • Wake or sleep EEG within the last 12 months showing epileptic discharges.
  • Attending a regular school.
  • Exclusion criteria
  • Irregular sleep-wake rhythm
  • Shift work
  • Daytime sleep
  • Excessive sweating
  • Obesity
  • Sleep, psychiatric, neurological or physical disorders or illnesses other than epilepsy
  • Hearing disorder
  • Travelling across 2 or more time zones within the last month
  • Pregnancy
  • Skin allergy or very sensitive skin
  • Drug and medication use or abuse other than for the treatment of epilepsy
  • Daily nicotine use
  • High caffeine consumption, including coffee, black and green tea, mate, cola, energy drinks, and iced tea
  • \<16 years: \>1 servings/day = \>80 mg caffeine
  • \>=16 years: \>2 servings/day = \>160 mg caffeine
  • Alcohol consumption
  • \<16 years: any alcohol
  • 16-17 years: \>3-4 standard servings per week
  • \>=18 years: \>1 standard serving per day (\>14 mg)
  • Inability to follow the procedures of the study For patients with epilepsy:
  • Epilepsy syndromes with a high risk of seizure occurrence during the study night
  • Generalized motor and/or focal motor seizure frequency \>1/week
  • Generalized motor and/or focal motor seizure within 24h before the study night
  • History of convulsive status epilepticus
  • History of seizures provoked by sleep deprivation
  • Treatment with corticosteroids, immunosuppressants or vagus nerve stimulation

Exclusion

    Key Trial Info

    Start Date :

    July 29 2020

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    December 1 2025

    Estimated Enrollment :

    120 Patients enrolled

    Trial Details

    Trial ID

    NCT04716673

    Start Date

    July 29 2020

    End Date

    December 1 2025

    Last Update

    January 20 2021

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    University Children's Hospital Zurich

    Zurich, Switzerland, 8032